These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 31714934)
1. Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia. Kebede A; Beyene D; Yenew B; Diriba G; Mehamd Z; Alemu A; Amare M; Ameni G PLoS One; 2019; 14(11):e0225205. PubMed ID: 31714934 [TBL] [Abstract][Full Text] [Related]
2. Analysis of unsuccessful tests and the effect of prolonged clinical sample preprocessing in the GeneXpert MTB/RIF assay. Wei JH; Qian XQ; Wan YM; Zhao XK; Zhang CY; Guo W; Zhu ZQ BMC Infect Dis; 2024 Aug; 24(1):770. PubMed ID: 39090540 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis. Fantahun M; Kebede A; Yenew B; Gemechu T; Mamuye Y; Tadesse M; Brhane B; Jibriel A; Solomon D; Yaregal Z PLoS One; 2019; 14(9):e0222402. PubMed ID: 31525214 [TBL] [Abstract][Full Text] [Related]
4. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation study. Tadesse M; Abebe G; Bekele A; Bezabih M; Yilma D; Apers L; de Jong BC; Rigouts L Clin Microbiol Infect; 2019 Aug; 25(8):1000-1005. PubMed ID: 30583052 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of GeneXpert Habous M; E Elimam MA; Kumar R; L Deesi ZA Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154 [TBL] [Abstract][Full Text] [Related]
6. Improved case detection using Xpert Kanade SR; Nataraj G; Mehta PR Indian J Med Microbiol; 2018; 36(4):590-593. PubMed ID: 30880713 [TBL] [Abstract][Full Text] [Related]
7. Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia. Alemu A; Tadesse M; Seid G; Mollalign H; Eshetu K; Sinshaw W; Abebaw Y; Amare M; Dagne B; Diriba G; Yenew B; Getu M; Zerihun B BMC Infect Dis; 2020 Jan; 20(1):87. PubMed ID: 32000702 [TBL] [Abstract][Full Text] [Related]
8. Impact of Xpert MTB/RIF in the Diagnosis of Childhood Tuberculosis in Rural Ethiopia. Pérez-Butragueño M; Ramos-Rincón JM; Tesfamariam A; Comeche B; Mohammed N; Tiziano G; Endirays J; Biru D; Elala T; Edri A; Prieto L; Górgolas M J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35848941 [TBL] [Abstract][Full Text] [Related]
9. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study. Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406 [TBL] [Abstract][Full Text] [Related]
10. Detection of Diriba G; Alemu A; Tola HH; Eshetu K; Yenew B; Amare M; Dagne B; Mollalign H; Sinshaw W; Abebaw Y; Seid G; Tadesse M; Zerihun B; Getu M; Moga S; Meaza A; Gamtesa DF; Tefera Z; Wondimu A; Hailu M; Buta B; Getahun M; Kebede A IJID Reg; 2022 Dec; 5():97-103. PubMed ID: 36247095 [TBL] [Abstract][Full Text] [Related]
11. Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia. Abebaw Y; Kebede A; Eshetu K; Tesfaye E; Tadesse M; Sinshaw W; Amare M; Gamtesa DF; Zerihun B; Getu M; Seid G; Yalew A; Diriba G PLoS One; 2022; 17(6):e0269601. PubMed ID: 35679308 [TBL] [Abstract][Full Text] [Related]
12. Xpert MTB/RIF assay for the diagnosis of Ejeta E; Beyene G; Bonsa Z; Abebe G J Clin Tuberc Other Mycobact Dis; 2018 Aug; 12():14-20. PubMed ID: 31720393 [TBL] [Abstract][Full Text] [Related]
13. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues. Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495 [TBL] [Abstract][Full Text] [Related]
16. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia. Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid. Rufai SB; Singh A; Singh J; Kumar P; Sankar MM; Singh S; J Infect; 2017 Aug; 75(2):125-131. PubMed ID: 28501491 [TBL] [Abstract][Full Text] [Related]
18. A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns. Donkeng-Donfack VF; Tchatchueng-Mbougua JB; Abanda NN; Ongboulal SM; Djieugoue YJ; Kamdem Simo Y; Mekemnang Tchoupa M; Bekang Angui F; Kuate Kuate A; Mbassa V; Mvondo Abeng Belinga E; Eyangoh S BMC Infect Dis; 2022 Mar; 22(1):219. PubMed ID: 35246071 [TBL] [Abstract][Full Text] [Related]